Literature DB >> 16609093

Recent trials in hypertension: compelling science or commercial speech?

Bruce M Psaty1, Noel S Weiss, Curt D Furberg.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh：

Substances：

Year:  2006        PMID： 16609093     DOI： 10.1001/jama.295.14.1704

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  9 in total

Review 1.  Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study.

Authors:  Veronica Yank; Drummond Rennie; Lisa A Bero
Journal:  BMJ       Date:  2007-11-16

2.  Construction and assumptions of models should be explicit.

Authors:  Tom Fahey
Journal:  BMJ       Date:  2007-04-21

3.  Comparator bias: why comparisons must address genuine uncertainties.

Authors:  Howard Mann; Benjamin Djulbegovic
Journal:  J R Soc Med       Date:  2013-01       Impact factor: 5.344

4.  Defining "quality of care" persuasively.

Authors:  Maya J Goldenberg
Journal:  Theor Med Bioeth       Date:  2012-08

5.  Promoting transparency in pharmaceutical industry-sponsored research.

Authors:  Joseph S Ross; Cary P Gross; Harlan M Krumholz
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

6.  Should β blockers no longer be considered first-line therapy for the treatment of essential hypertension without comorbidities?

Authors:  William J Elliott; W Kurtis Childers
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

7.  Observational comparative effectiveness studies of drug therapies: high-quality answers or important clinical questions?: comment on "Comparative effectiveness of 2 β-blockers in hypertensive patients".

Authors:  James S Floyd; Bruce M Psaty
Journal:  Arch Intern Med       Date:  2012-10-08

8.  Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study.

Authors:  Inbal Boger-Megiddo; Susan R Heckbert; Noel S Weiss; Barbara McKnight; Curt D Furberg; Kerri L Wiggins; Joseph A C Delaney; David S Siscovick; Eric B Larson; Rozenn N Lemaitre; Nicholas L Smith; Kenneth M Rice; Nicole L Glazer; Bruce M Psaty
Journal:  BMJ       Date:  2010-01-25

9.  Interactions between the adducin 2 gene and antihypertensive drug therapies in determining blood pressure in people with hypertension.

Authors:  Sharon L R Kardia; Yan V Sun; Sara C Hamon; Ruth Ann Barkley; Eric Boerwinkle; Stephen T Turner
Journal:  BMC Med Genet       Date:  2007-09-13       Impact factor: 2.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.